Aldevron provides contract manufacturing and scientific services. We specialize in plasmid DNA, protein production, and antibody generation.
PLASMID DNA PRODUCTION
With the successful completion of over 50,000 projects, we have developed unsurpassed expertise in plasmid manufacturing. Using proprietary technology, Aldevron manufactures DNA for a wide range of research, preclinical, clinical, and diagnostic applications (1 mg to 100 g).
PROTEIN PRODUCTION
Aldevron offers a wide range of protein services including host cell optimization, expression screening, process development, contract production, enzyme and antibody assay design, and more. Proteins produced by Aldevron are used for a wide range of agriculture and biomedical applications from research grade to full cGMP.
ANTIBODY GENERATION
GENOVAC Antibody Technology supports all project types from reagent antibodies to diagnostic and therapeutic applications with high success rates. Based on many years of experience, our immunization technology has been developed to cater for all protein targets where other methods have failed (including e.g. GPCRs). Our custom antibodies have been validated in over 130 publications and patents for more than 500 clients worldwide. Additional services include antibody processing, production, labeling, characterization and sequencing.
Specialties
plasmid DNA, recombinant protein, antibody, genomic DNA, genetic immunization
Aldevron Activity on LinkedIn
-
Aldevron Aldevron Webinar: We are going to be offering our Genetic Immunization & Screening Technologies Webinar on March 2nd, twice! Please register online soon, as there is limited space. Title: Aldevron Antibody Development Webinar: Genetic Immunization Date: Friday, March 2, 2012 Time: 9:00 AM - 10:00 AM EST https://www4.gotomeeting.com/register/274158127 Title: Aldevron Antibody Development Webinar: Genetic Immunization Date: Friday, March 2, 2012 Time: 12:00 PM - 1:00 PM EST https://www4.gotomeeting.com/register/698193583 -
Aldevron Antibody Webinar on March 2: Genetic immunization makes it possible to create high quality antibodies directly from an antigen specific DNA sequence without the use of conventional technologies. Aldevron’s genetic immunization technology has been used to make antibodies against many difficult targets including GPCRs and ion channels. These monoclonal and polyclonal antibodies have been used in research, diagnostics, and therapeutics. Our proprietary screening technology allows for the selection of antibodies that recognize native proteins. Send an email to webinars@aldevron.com to register -
-
Aldevron Aldevron wil be attending and presenting at the 5th Annual Proteins Congress, 2nd - 3rd April 2012, Radisson Blu Portman, London, UK Please contact Laure Marmin (lmarmin@aldevron.com) to set up a meeting at the event or in the London area. We are also pleased to extend a Guest Discounts for the event. All Pharma Companies and Academic Institutions – Normal price £799 +VAT, discounted price £450 +VAT – please quote “ALDPRO450” Please contact Ross McIvor r.mcivor@oxfordglobal.co.uk and quote the relevant code as shown above to register. -
Aldevron Tom Lynch will be attending the Phacilitate Cell & Gene Therapy/Protein Forum in Washington, DC at the end of the month. Contact him directly if you would like him to set up a visit at the event or your facility in the area. (lynch@aldevron.com) http://www.phacilitate.co.uk/
